|
|
||||||||
The Annals of Thoracic Surgery, Vol 56, 916-922, Copyright © 1993 by The Society of Thoracic Surgeons
JC Hall, K Christiansen, MJ Carter, MG Edwards, AJ Hodge, MA Newman, TT Nicholls and J Hall
This clinical trial, which was composed of 1,031 adults undergoing cardiac
operations, compared the efficacy of a single dose of 1 g of ceftriaxone
with a 48-our regimen consisting of flucloxacillin and gentamicin. There
was no significant difference (p = 0.89) in the overall incidence of major
infections: 30 of 515 patients (5.8%; 95% confidence interval, 5.4% to
6.2%) taking ceftriaxone and 29 of 516 patients (5.6%; 95% confidence
interval, 5.2% to 6.0%) taking flucloxacillin and gentamicin. Subgroup
analyses, with a lower statistical power, failed to show a significant
difference between patients who received ceftriaxone and those who received
flucloxacillin/gentamicin: major sternal wound infections arose in 2.7% of
the patients taking ceftriaxone versus 1.6% in those on the 48-hour regimen
(p = 0.20) and major limb wound infections arose in 4.2% and 5.4%,
respectively (p = 0.44). Single-dose prophylaxis was associated with fewer
intravenous administrations (864 doses versus 9,570 doses) and cost less
(A$17,248 versus A$78,510). Although the regimen that included gentamicin
was associated with the greatest biochemical impairment of renal function,
the overall toxicity for both groups was low. We conclude that a single
dose of ceftriaxone provided cost- efficient prophylaxis for adults
undergoing cardiac operations when compared with a 48-hour regimen of
gentamicin and flucloxacillin. The general principle revealed by our data
is that the short-term administration of an appropriate antibiotic regimen
represents optimal prophylaxis for patients undergoing cardiac procedures.
ARTICLES
Antibiotic prophylaxis in cardiac operations
Division of Surgery, Royal Perth Hospital, Australia.
This article has been cited by other articles:
![]() |
F. H. Edwards, R. M. Engelman, P. Houck, D. M. Shahian, and C. R. Bridges The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration Ann. Thorac. Surg., January 1, 2006; 81(1): 397 - 404. [Full Text] [PDF] |
||||
![]() |
O. Friberg, R. Svedjeholm, B. Soderquist, H. Granfeldt, T. Vikerfors, and J. Kallman Local Gentamicin Reduces Sternal Wound Infections After Cardiac Surgery: A Randomized Controlled Trial Ann. Thorac. Surg., January 1, 2005; 79(1): 153 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
U.-S. Salminen, T. U. T. Viljanen, V. V. Valtonen, T. E. H. Ikonen, A. E. Sahlman, and A. L. J. Harjula Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery J. Antimicrob. Chemother., August 1, 1999; 44(2): 287 - 290. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |